Functional Genetics, Inc. - Using Innovative Science to Develop New Therapeutics for Infectious Diseases

Copyright © 2009 Functional Genetics Inc. All rights reserved.
  • Home
  • Company Overview
    • History
    • Management
    • Careers
    • News
  • Product Pipeline
    • Product Development
    • FGI-101
    • FGI-102
    • FGI-103
    • FGI-104
    • FGI-106
  • Science & Discovery
    • RHGP
    • Host Oriented Therapeutics
  • Publications
  • Business Development
    • Collaborative Alliances
  • Contact Us
    • Address and Directions
Publications

Publications

  • November 11, 2009 -- A Functional Mouse Retroposed Gene RPS23r1 Reduces Alzheimer's Beta-Amyloid Levels and Tau Phosphorylation
  • September 29, 2009 -- Identification of novel host-oriented targets for Human Immunodeficiency Virus type I using Random Homozygous Gene Perturbation
  • August 14, 2009 -- Development of a Broad-Spectrum Antiviral With Activity Against Ebola Virus
  • June, 2009 -- Function-First Approaches to Improve Target Identification in Cancer
  • April 12, 2009 -- Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation
  • February 20, 2009 -- The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza
  • January 5, 2009 -- FGI-104: a broad-spectrum small molecule inhibitor of viral infection
  • October 15, 2003 -- In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding
  • May 3, 1996 -- tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian Cells